These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 10742386

  • 1. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhäuser M.
    Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
    [Abstract] [Full Text] [Related]

  • 2. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B, Camus S, Yagello M, Gluckman JC.
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
    Dalloul AH, Patry C, Salamero J, Canque B, Grassi F, Schmitt C.
    J Immunol; 1999 May 15; 162(10):5821-8. PubMed ID: 10229816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.
    J Leukoc Biol; 2004 Sep 15; 76(3):623-33. PubMed ID: 15197237
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K, Seeger K, Scheibenbogen C, Bender R, Abdulla M, Süssmilch S, Salama A, Moldenhauer A.
    J Leukoc Biol; 2009 Mar 15; 85(3):563-73. PubMed ID: 19129484
    [Abstract] [Full Text] [Related]

  • 9. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M.
    Cancer Res; 2002 May 15; 62(10):2861-8. PubMed ID: 12019165
    [Abstract] [Full Text] [Related]

  • 10. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM, Borleri G, Conti E, Ciocca A, Salvi A, Micò C, Introna M, Rambaldi A.
    Exp Hematol; 2006 Apr 15; 34(4):475-85. PubMed ID: 16569594
    [Abstract] [Full Text] [Related]

  • 11. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A, Beyer M, Wolf J.
    Eur J Haematol; 2008 Oct 15; 81(4):281-8. PubMed ID: 18573171
    [Abstract] [Full Text] [Related]

  • 12. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.
    Transfusion; 2008 May 15; 48(5):861-70. PubMed ID: 18208411
    [Abstract] [Full Text] [Related]

  • 13. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.
    Lee J, Sait SN, Wetzler M.
    Int Immunol; 2004 Oct 15; 16(10):1377-89. PubMed ID: 15302850
    [Abstract] [Full Text] [Related]

  • 14. [Dendritic cells (DC) induced from acute myeloid leukemia (AML) cells with cytokine cocktails].
    Yan KH, You SG, Bian SG, Ma GJ, Ge W, Ma S, Liu SH, Zhao CH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul 15; 24(7):365-8. PubMed ID: 12941192
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ.
    J Clin Apher; 2004 Jul 15; 19(2):66-70. PubMed ID: 15274198
    [Abstract] [Full Text] [Related]

  • 16. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
    He X, You S, Bian S.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec 15; 22(12):629-32. PubMed ID: 16200709
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
    Curti A, Pandolfi S, Aluigi M, Isidori A, Alessandrini I, Chiodoni C, Testoni N, Colombo MP, Baccarani M, Lemoli RM.
    Exp Hematol; 2005 Dec 15; 33(12):1521-30. PubMed ID: 16338495
    [Abstract] [Full Text] [Related]

  • 18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 15; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J, Rolinski J, Hus I, Dmoszynska A, Wiesneth M, Schmitt M.
    Int J Oncol; 2006 Apr 15; 28(4):855-61. PubMed ID: 16525634
    [Abstract] [Full Text] [Related]

  • 20. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C, Liepert A, Dreyig J, Kremser A, Kroell T, Freudenreich M, Schmid C, Schweiger C, Tischer J, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Jun 15; 33(5):523-37. PubMed ID: 20463595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.